Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

HHS Provider Relief Funds Reporting Requirements: Important Updates Every Provider Should Know

Client Alert

HHS continues to revise its reporting requirements for the use of the Provider Relief Funds. Providers with more than $10,000 in Provider Relief Fund payments must report on the use of the funds through December 31, 2020. The reporting window will begin on January 15, 2021 and providers must complete reporting obligations for FY 2020 by February 15, 2021 through a portal designed by HHS. However, providers that have unexpended funds as of December 31, 2020, will have an additional 6 months to use the remaining funds through June 30, 2021. These providers must submit a second and final report no later than July 31, 2021.  

Providers must use the Provider Relief Funds for increased healthcare related expenses attributable to COVID-19 or lost revenues due to COVID-19. HHS has made clear that providers that do not have or do not anticipate that they will have eligible expenses or lost revenue in excess of the Provider Relief Funds must return the funds by July 31, 2021. Providers must carefully calculate increased expenses attributable to COVID-19 and lost revenue due to COVID-19 in accordance with the new guidance issued by HHS through a 2-step analysis.  

Step 1:  Calculate Healthcare Expenses Attributable to COVID-19

First, providers must calculate healthcare expenses that are (1) attributable to COVID-19, and (2) not reimbursed by another source or not obligated to be reimbursed by another source. The healthcare expenses are divided into two categories: General and Administrative (G&A expenses) and healthcare-related operating expenses. The intent of the Provider Relief Funds is to reimburse marginal increased expenses due to COVID-19. Providers that received between $10,000 and $499,999 in aggregate Provider Relief Funds will only need to report healthcare related expenses attributable to COVID-19 less other sources of reimbursement (insurance payments, government assistance, etc.) separately in the two categories of G&A expense and healthcare-related operating expenses. Providers that received $500,000 or more in Provider Relief Funds will be required to report more detailed expense information using worksheets that will be in the portal.  

G&A expenses include expenses such as mortgage/rent, insurance costs, personnel and fringe benefits, lease payments, utilities and operations, etc. Provider Relief Funds can only be used to cover G&A expenses over and above amounts that have been reimbursed from other sources such as insurance payments and funds received from government sources (such as PPP, EIDL, etc.).  HHS has issued detailed FAQs regarding the definition of G&A expenses, but we expect more guidance to be issued regarding how increased expenses are calculated and offset by other monies received by the provider.  

The FAQs outline a few methodologies from which a provider can choose, based on the provider’s accounting methodology and record-keeping. The provider can net G&A expenses against insurance payments and other funds received (such as PPP, EIDL, etc.). The provider can also calculate the increased incremental cost to provide services, such as an office visit, due to incremental expense. However, the provider must offset the incremental cost by any increased reimbursement received by the provider to compensate for the increased costs. Providers can also calculate incremental expenses separately such as additional security personnel, increased hazard pay, increased utility costs of temporary facilities, etc. However, if the provider applied any funding or grants, such as PPP funds, the provider cannot apply these expenses to the Provider Relief Funds. 

Healthcare-related operating expenses include expenses such a supplies, equipment, IT, facilities, employees, and other similar expenses. The Provider Relief Funds can only be used for costs attributable to COVID-19. Providers can compare costs and expenses from 2019 to the same costs and expense from 2020 in order to determine the incremental increase due to COVID-19. For example, providers should calculate the increased costs in PPE supplies in 2019 compared to PPE supplies in 2020 (less any grant or funding received by the provider for such items). 

Step 2:  Calculate Lost Revenues Attributable to COVID-19

If providers still have unused Provider Relief Funds, the provider must allocate the Provider Relief Funds to lost revenues due to COVID-19. The updated reporting instructions reverse initial instructions that allowed providers to calculate lost revenues based on a reasonable accounting methodology through a snapshot of March and April 2020 losses and budgeted versus actual revenues. The new reporting requirements require providers to compare 2019 patient care revenues to 2020 patient care revenues and the year-over-year net change in patient care revenues from 2019 to 2020.  

Lost Revenues Equation:

     2019 Patient Care Revenues

-    2020 Patient Care Revenues

  = Net Change (maximum amount to which Provider Relief Funds can be applied)

Providers must report patient revenues by payor source (Medicare Part A+B, Medicare Part C, Medicaid/CHIP, commercial insurance, self-pay) as well as other income. Other income would include amounts received from other sources for patient care services (e.g. deductibles, copayments, coinsurance amounts).   

If the Provider Relief Funds are not fully expended by December 31, 2020, the provider can use the 6-month period from January 1, 2021-June 30, 2021 and compare patient care revenues to the same 6-month period in 2019.  

Other Reporting Requirements

Providers must also report other assistance received in 2020 such as Coronavirus Relief Funds from the Treasury, IRS, SBA, CARES Act/PPP, etc.; FEMA CARES Act; CARES Act testing; local, state, and tribal government assistance; business insurance (e.g. business interruption); and other assistance (which includes interest earned on the Provider Relief Funds). Interest must be added to the total Provider Relief Fund amount and expended towards the appropriate use of the funds. 

Providers must also provide quarterly data on non-financial information. Providers must report personnel metrics by category (full-time, part-time, contract, etc.) as well as total re-hires, total new hires, and total personnel separations – all by category. Providers must report certain patient metrics including in-person and telehealth visits, as well as total number of admissions and resident patients. In addition, providers must report on facility metrics including staffed beds for medical/surgical, critical care, and other beds. 

Finally, providers that underwent changes of ownership or certain divestitures will be required to report the change in ownership.

Providers should continue to be cognizant of their record-keeping obligations as well as balance-billing prohibitions. For more information on the HHS Provider Relief Fund Reporting Requirements, please visit our website at www.bmdllc.com. For more information on the HHS Provider Relief Funds, please contact Amanda Waesch at alwaesch@bmdllc.com or 330-253-9185.


Employer Liability for COVID-19 Vaccine Side Effects

As employers encourage or require employees to obtain a COVID-19 vaccine, they should be aware of OSHA recording obligations and potential workers’ compensation liability. Though OSHA has yet to revise its COVID-19 guidance in response to the latest CDC recommendations, OSHA has revised its position regarding the recording of injury or illness resulting from the vaccine. Until now, OSHA required an employer to record an adverse reaction when the vaccine was required for employees and the injury or illness otherwise met the recording criteria (work-related, a new case, and meets one or more of the general recording criteria). OSHA has reversed course and announced that it will not require recording adverse reactions until at least May 2022, irrespective of whether the employer requires the vaccine as a condition of employment. In its revised COVID-19 FAQs, OSHA states:

The New Rule 1.510 - Radical Change for Summary Judgement Procedure in Florida

In civil litigation, where both sides participate actively, trial is usually required at the end of a long, expensive case to determine a winner and a loser. In federal and most state courts, however, there are a few procedural shortcuts by which parties can seek to prevail in advance of trial, saving time, money and annoyance. The most common of these is the “motion for summary judgment”: a request to the court by one side for judgment before trial, generally on the basis that the evidence available reflects that a win for that party is legally inevitable and thus required. Effective May 1, 2021, summary judgment procedure in Florida has radically changed.

Vacating, Modifying or Correcting an Arbitration Award Under R.C. 2711.13: Three-Month Limitation Maximum; Not Guaranteed Amount of Time

In a recent decision, the Supreme Court of Ohio held that neither R.C. 2711.09 nor R.C. 2711.13 requires a court to wait three months after an arbitration award is issued before confirming the award. R.C. 2711.13 provides that “after an award in an arbitration proceeding is made, any party to the arbitration may file a motion in the court of common pleas for an order vacating, modifying, or correcting the award.” Any such motion to vacate, modify, or correct an award “must be served upon the adverse party or his attorney within three months after the award is delivered to the parties in interest.” In BST Ohio Corporation et al. v. Wolgang, the Court held the three-month period set forth in R.C. 2711.13 is not a guaranteed time period in which to file a motion to vacate, modify, or correct an arbitration award. 2021-Ohio-1785.

EEOC Provides Updated Guidance Regarding Employer COVID-19 Vaccine Policies

On May 28, 2021, the U.S. Equal Employment Opportunity Commission updated its guidance regarding employer COVID-19 vaccination policies. The new guidance provides much-needed clarification of expectations for employers seeking to promote workplace safety and prevent the spread of COVID-19, including discussion of mandatory vaccination policies, voluntary vaccination incentives, and accommodation of employees based on disability or sincerely held religious beliefs. The full text of the update is found in Section K of the EEOC’s COVID Q&A document. You can also learn more about these and other developments from BMD's Bryan Meek and Monica Andress through the Employment Law After Hours YouTube channel, available here.

What Telemedical Barriers Practices Face and How They Can Manage Them

The onset of the COVID-19 pandemic has led to many businesses and industries having to rapidly adapt new practices in order to stay profitable, and the healthcare industry is no exception. Although telehealth tools and practices have existed and been used since the Vietnam War, the pandemic has caused many individual healthcare practices to heavily rely on telehealth as a large portion of their service mix in order to continue to provide care for patients. Because of this rapid adoption of telehealth practices in order to combat the restrictions of COVID-19, the telemedicine industry’s revenue has exploded in the last year. Experts predict that telehealth will continue to grow in use beyond the current pandemic, estimating the industry’s worth to be $25 billion by 2025. However, this rapid adoption of telehealth was prompted out of need and has not been without its own barriers that practices now face.